Solid Biosciences Inc.

NASDAQ:SLDB

Biotechnology

Healthcare
$6.23 +3.63%

+$0.27 today

Market cap
$695.33M
Beta
2.43
P/E (TTM)
-4.3
EPS (TTM)
-$1.75
52W Low $3.79High $8.87

Volume 1.13M

Average 1.39M

Balance Sheet

Inspect the capital base behind the business.

Assets

$232.54M

FY 2025 · Annual

+23.3% YoY

Liabilities

$52.53M

FY 2025 · Annual

+2.2% YoY

Equity

$180.01M

FY 2025 · Annual

+31.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents119.14M155.38M74.02M80.24M59.9M
Short-term Investments88.64M58.34M49.63M68.69M127.95M
Net Receivables110K0000
Inventory00000
Other Current Assets8.71M3M2.11M1.65M17.61M
Total Current Assets222.61M219.64M129.73M157.3M205.46M
Property, Plant & Equipment (Net)7.6M38.61M33.16M29.04M26.09M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets2.16M2.01M2.04M2.32M991K
Total Non-current Assets9.77M40.61M35.21M31.36M27.08M
Total Assets232.38M260.25M164.94M188.66M232.54M
Account Payables4.46M3.24M2.03M4.24M3.22M
Short-term Debt00002.1M
Tax Payables00000
Deferred Revenue8.08M0000
Other Current Liabilities3.12M8.38M5.95M9.37M28.15M
Total Current Liabilities23.6M22.51M14.52M30.26M33.47M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities096K000
Total Non-current Liabilities568K26.08M23.94M21.16M19.06M
Total Liabilities24.17M48.59M38.46M51.42M52.53M
Common Stock7K20K20K40K79K
Retained Earnings(476.76M)(562.74M)(658.75M)(783.45M)(957.78M)
Accumulated OCI(45K)(68K)15K47K52K
Other Stockholders Equity00000
Minority Interest00000
Total Equity208.21M211.67M126.48M137.25M180.01M
Total Debt2.06M28.55M26.27M24.18M21.16M
Net Debt(117.07M)(126.84M)(47.75M)(56.06M)(38.74M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$297.7M
Short-term Investments$83.6M
Other Current$15.5M
Total Current Assets$396.8M
PP&E (Net)$25.2M
Long-term Investments$708.0K
Other Non-current$183.0K
Total Non-current Assets$26.1M
Total Assets$422.9M

Analysis

Selected assets total $422.9M for Latest. The largest visible component is Cash & Equivalents at $297.7M, about 70.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 6, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 26, 2026
4Statement of changes in beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 6, 2026

How much cash does SLDB have?

Solid Biosciences Inc. (SLDB) reported $59.90M in cash and equivalents in fiscal 2025.

How much debt does SLDB carry?

Solid Biosciences Inc. (SLDB) reported $21.16M of total debt, with net debt of -$38.74M.